NEW YORK, March 10, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of The Southern Company securities (NYSE:SO) from April 25, 2012 through October 29, 2013, inclusive (the “Class Period”) of the important March 24, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Southern Company investors under the federal securities laws.
To join the Southern Company class action, go to http://rosenlegal.com/cases-1037.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and misleading statements and/or failed to disclose adverse information regarding the progress of the Kemper Plant, assuring investors that the project would be completed by the critical May 2014 deadline, even when cost overruns and other delays began to materialize. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1037.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



